Lauren P. Silvernail, CFO & CBO at Revance Therapeutics, Inc. (RVNC), sold 5,748 shares at $30.25 ($174K) on 2018-05-22, disclosed to the SEC on 2018-05-24.
Seasonal sale ($174k) by CFO & CBO — this insider has traded RVNC in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.25 | 2,874 | $87K | 50.0% |
| 2 | $30.25 | 2,874 | $87K | 50.0% |
| Total | $30.25 avg | 5,748 | $174K | 100% |
| Filing → |
| EOLS | SELL | 2022-03-10 | $198K | — | Filing → |
| EOLS | SELL | 2021-08-12 | $320K | — | Filing → |
| EOLS | SELL | 2021-01-26 | $20K | — | Filing → |